Skip to main content

Effect of aluminum on normal and uremic rats: Tissue distribution, vitamin D metabolites, and quantitative bone histology

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The effects of intraperitoneal aluminum chloride (1.5 mg aluminum/kg/day for 9 weeks) were studied in normal and uremic rats. Parameters measured included tissue aluminum, serum vitamin D metabolites, and quantitative bone histology.

Aluminum administration increased tissue concentrations of this metal in uremic and nonuremic animals. Bone aluminum concentrations were higher in uremic rats (121 ± 27 mg/kg compared to 47 ± 4), whereas liver values were higher in the nonuremic group (175 ± 47 mg/kg compared to 100 ± 36). Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D were reduced in uremia, but aluminum was without apparent effect on any vitamin D metabolite.

Aluminum, in the doses administered, caused no skeletal changes in nonuremic animals. Some uremic, non-aluminum-treated rats developed osteomalacia and marrow fibrosis. However, osteomalacia was more severe and the osteoclast count was higher in the uremic, aluminum-treated rats. In this group of animals the mineral apposition rate was reduced at the metaphyseal endosteum but increased at the periosteum, indicating different control mechanisms at the two sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome: Possible aluminum intoxication. N Engl J Med 294:184–188

    Article  CAS  PubMed  Google Scholar 

  2. Hodsman AB, Sherrard DJ, Wong EGC, Brickman AS, Lee DBN, Alfrey AC, Singer FR, Norman AW, Coburn JW (1981) Vitamin D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. Ann Int Med 94:629–637

    CAS  PubMed  Google Scholar 

  3. Recker RR, Blotcky AJ, Leffler JA, Rack EP (1977) Evidence for aluminum absorption from the gastrontestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med 90:810–815

    CAS  PubMed  Google Scholar 

  4. Klein GL, Alfrey AC, Miller NL, Sherrard DJ, Hazlett TK, Ament ME, Coburn JW (1981) Aluminum loading during long-term total parenteral nutrition: A possible cause of bone disease? Proc. 3rd Annual Meeting Am. Soc. Bone and Min. Res. 3:21 (abstr)

    Google Scholar 

  5. Parkinson IS, Ward MK, Feest TG, Fawcett RWP, Kerr DNS (1979) Fracturing dialysis osteodystrophy and dialysis encephalopathy. Lancet 1:406–409

    Article  CAS  PubMed  Google Scholar 

  6. Pierides AM, Frohnert PP (1981) Aluminum related dialysis osteomalacia and dementia after prolonged use of the Redy cartridge. Trans Amer Soc Artif Int Organs 27:629–633

    CAS  Google Scholar 

  7. Alfrey AC, Hegg A, Craswell P (1980) Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr 33:1509–1516

    CAS  PubMed  Google Scholar 

  8. Berlyne GM, Yagil R, Ben Ari J, Weinberger G, Knopf E, Danovitch GM (1972) Aluminum toxicity in rats. Lancet 1:564–568

    Article  CAS  PubMed  Google Scholar 

  9. Thurston H, Gilmore GR, Swales JD (1972) Aluminum retention and toxicity in chronic renal failure. Lancet 1:881–883

    Article  CAS  PubMed  Google Scholar 

  10. Arieff AI, Cooper JD, Armstrong D, Lazarowitz VC (1979) Dementia, renal failure and brain aluminum. Ann Intern Med 90:741–747

    CAS  PubMed  Google Scholar 

  11. Ellis HA, McCarthy JH, Herrington J (1979) Bone aluminum in haemodialysed patients and in rats injected with aluminum chloride: Relationship to impaired bone mineralisation. J Clin Pathol 32:832–844

    CAS  PubMed  Google Scholar 

  12. LeGendre GR, Alfrey AC (1976) Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption analysis of a chelate. Clin Chem 22:53–56

    CAS  PubMed  Google Scholar 

  13. Mason RS, Posen S (1977) Some problems associated with assay of 25-hydroxycalciferol in human serum. Clin Chem 23:806–810

    CAS  PubMed  Google Scholar 

  14. Haddad JG, Chyu KJ (1971) Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol 33:992–995

    Article  CAS  Google Scholar 

  15. Mason RS, Lissner D, Grunstein H, Posen S (1980) A simplified assay for dihydroxylated vitamin D metabolites in human serum: Application to hyper- and hypovitaminosis D. Clin Chem 26:444–450

    CAS  PubMed  Google Scholar 

  16. Eisman JA, Hamstra AJ, Kream BE, DeLuca HF (1976) A sensitive, precise and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. Arch Biochem Biophys 176:235–243

    Article  CAS  PubMed  Google Scholar 

  17. Taylor CM, Hughes SE, de Silva P (1976) Competitive protein-binding assay for 24,25-dihydroxycholecalciferol. Biochem Biophys Res Commun 70:1243–1249

    Article  CAS  PubMed  Google Scholar 

  18. Evans RA, Howlett CR, Dunstan CR, Hills E (1982) The effect of long term low-dose diphosphonate treatment on rat bone. Clin Orthop Rel Res 165:290–299

    CAS  Google Scholar 

  19. Dunstan CR, Evans RA (1980) Quantitative bone histology: A new method. Pathology 12:255–264

    CAS  PubMed  Google Scholar 

  20. Baylink D, Stauffer M, Wergedal J, Rich C (1970) Formation, mineralization and resorption of bone in vitamin D-deficient rats. J Clin Invest 49:1122–1134

    Article  CAS  PubMed  Google Scholar 

  21. Evans RA, Dunstan CR, Baylink DJ (1979) Histochemical identification of osteoclasts in undecalcified sections of human bone. Mineral Electrolyte Metab 2:179–185

    CAS  Google Scholar 

  22. Jowsey J, Kelly PJ, Riggs BL, Bianco AJ Jr, Scholz DA, Gershon-Cohen J (1965) Quantitative microradiographic studies of normal and osteoporotic bone. J Bone Joint Surg 47A:785–806

    Google Scholar 

  23. Teitelbaum SL (1980) Pathological manifestations of osteomalacia and rickets. Clin Endocrinol Metab 9:43–62

    Article  CAS  PubMed  Google Scholar 

  24. Evans RA, Flynn J, Dunstan CR, George CRP, McDonnell GD (1982) Bone metabolism in chronic renal failure. Mineral Electrolyte Metab 7:207–218

    CAS  Google Scholar 

  25. Buchanan MRC, Ihle BU, Dunn CM (1981) Haemodialysis related osteomalacia: A staining method to demonstrate aluminum. J Clin Pathol 34:1352–1354

    CAS  PubMed  Google Scholar 

  26. Maloney NA, Ott S, Alfrey AC, Coburn JW, Sherrard DJ (1982) Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 99:206–216

    CAS  PubMed  Google Scholar 

  27. Cournot-Witmer R, Zingraff J, Plachot JJ, Escaig F, LeFevre R, Boumati P, Bourdeau A, Garabedian M, Galle P, Bourdon R, Drueke T, Balsan S (1981) Aluminum localization in bone from hemodialyzed patients: Relationship to matrix maturation. Kidney Int 20:375–385

    CAS  PubMed  Google Scholar 

  28. Mayor GH, Keiser JA, Makdani D, Ku PK (1977) Aluminum absorption and distribution: Effect of parathyroid hormone. Science 197:1187–1189

    CAS  PubMed  Google Scholar 

  29. Malluche HH, Goldstein DA, Massry SG (1979) Management of renal osteodystrophy with 1,25(OH)2D3. II. Effects on histopathology of bone: Evidence for healing of osteomalacia. Mineral Electrolyte Metab 2:48–55

    Google Scholar 

  30. Thompson ER, Baylink DG, Wergedal JE (1975) Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. Endocrinology 97:283–289

    CAS  PubMed  Google Scholar 

  31. Parfitt AM (1979) Quantum concept of bone remodelling and turnover: Implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1–5

    CAS  PubMed  Google Scholar 

  32. Klein GL, Horst RL, Norman AW, Ament ME, Slatopolsky E, Coburn JW (1981) Reduced serum levels of 1α25 dihydroxyvitamin D during long-term total parenteral nutrition. Ann Intern Med 94:638–643

    CAS  PubMed  Google Scholar 

  33. Mason RS, Moddel D, McElduff A, Stewart JH, Mahony JF, Posen S (1979) The relevance of 25 hydroxycalciferol measurements in sera of patients with renal failure. Aust NZJ Med 9:257–260

    CAS  Google Scholar 

  34. Mason RS, Lissner D, Wilkinson M, Posen S (1980) Vitamin D metabolites and their relationship to azotaemic osteodystrophy. Clin Endocrinol 13:375–385

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chan, YL., Alfrey, A.C., Posen, S. et al. Effect of aluminum on normal and uremic rats: Tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int 35, 344–351 (1983). https://doi.org/10.1007/BF02405056

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02405056

Key words

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy